Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Tempo English
Support Tempo
LOGIN REGISTER
image-bahasa
image-language

Kimia Farma to Offer 2.7bn New Shares via Rights Issue

Translator

Ririe Ranggasari

Editor

Petir Garda Bhwana

19 August 2021 10:32 WIB

Kimia Farma pharmacy in Senen area, Jakarta, Monday, July 12, 2021. It is planned that the price of one dose of Kimia Farma vaccine is set at IDR 321,660 per dose, with a service price of IDR 117,910 for one injection. Tempo/Tony Hartawan

TEMPO.CO, Jakarta - State-owned pharmaceutical firm Kimia Farma (IDX: KAEF) held an extraordinary general meeting of shareholders (EGM) on Wednesday. Shareholders agreed to the company's plan of holding a rights issue, offering 2.78 billion new shares.

KAEF will issue up to 2.78 billion series B shares for Rp100 per share through a Limited Public Offering (PUT) I mechanism.

"The proceeds will be used to pay maturing loans, as working capital, and business development, including in the context of digital and IT system transformation," the management said in a statement received in Jakarta, August 19.

In the EGM, shareholders also agreed on other things including the enactment of the SOE Minister Regulation on CSR programs, changes in nomenclature, and its board of commissioners and directors overhaul.

Read: Kimia Farma Lowers Price of PCR Test to Rp495,000

ANTARA

Kimia Farma


Recommended

Kimia Farma: Sinopharm Vaccine for Booster Available for Public

12 Februari 2022

Kimia Farma: Sinopharm Vaccine for Booster Available for Public

Kimia Farma stated that the Indonesian people can now get the Sinopharm vaccine as a booster since the BPOM had issued its Emergency Use Authorization


Kimia Farma Lowers Price of PCR Test to Rp495,000

18 Agustus 2021

Kimia Farma Lowers Price of PCR Test to Rp495,000

Kimia Farma slashes the price of the Covid-19 PCR test to Rp495,000 following the Health Ministry's circular on the test price cap.


1.18 Mn More Doses of Sinopharm Vaccine Arrive in Indonesia: Kimia Farma

19 Juli 2021

1.18 Mn More Doses of Sinopharm Vaccine Arrive in Indonesia: Kimia Farma

Indonesia receives today 1.184 million more doses of Sinopharm vaccine, or equal to 592,000 vials.


Health Ministry Asserts People Not Obliged to Buy Covid-19 Vaccine

12 Juli 2021

Health Ministry Asserts People Not Obliged to Buy Covid-19 Vaccine

The Health Ministry spokesperson for Covid-19 vaccination, Siti Nadia Tarmizi, asserted that the paid Covid-19 vaccine program is not mandatory.


SOE Ministry Discloses Paid Covid-19 Vaccination Program

12 Juli 2021

SOE Ministry Discloses Paid Covid-19 Vaccination Program

SOE Minister's special staffer said the government would continue to run the free Covid-19 vaccination program despite there will be paid ones.


Kimia Farma Postpones Paid Covid-19 Vaccination Program

12 Juli 2021

Kimia Farma Postpones Paid Covid-19 Vaccination Program

Kimia Farma Corporate Secretary Ganti Winarno announced that his side postponed the implementation of paid Covid-19 vaccination.


Kimia Farma: Individually-Paid Vaccination Won't Hinder Govt's Program

12 Juli 2021

Kimia Farma: Individually-Paid Vaccination Won't Hinder Govt's Program

PT Kimia Farma was set to serve individually-paid Covid-19 vaccination as part of the Gotong Royong Vaccination program starting today, July 12.


Kimia Farma to Serve Individually-paid Vaccination in Eight Clinics

11 Juli 2021

Kimia Farma to Serve Individually-paid Vaccination in Eight Clinics

Kimia Farma to serve the first stage of Gotong Royong's individually-paid vaccination (VGR) in eight clinics in Java and Bali.


Kimia Farma Producing, Distributing Three Therapeutic COVID-19 Drugs

8 Juli 2021

Kimia Farma Producing, Distributing Three Therapeutic COVID-19 Drugs

Kimia Farma has said it is producing and distributing three variants of therapeutic COVID-19 drugs azithromycin, favipiravir, and remdesivir.


Kimia Farma Preps 7.5 Mn Doses of Sinopharm for Private Vaccination Program

28 Mei 2021

Kimia Farma Preps 7.5 Mn Doses of Sinopharm for Private Vaccination Program

Kimia Farma secretary Ganti Winarno said his side had signed a deal with COVID-19 vaccine manufacturer Sinopharm to import 7.5 million doses.